Android app Apple app link

InflaRx N.V. (IFRX) Stock Price, News, Quote & History - Yahoo Finance

By Yahoo! Finance   |   1 month ago
InflaRx N.V. (IFRX) Stock Price, News, Quote & History - Yahoo Finance

InflaRx N.V. is a biopharmaceutical company focusing on developing C5a inhibitors for autoimmune and inflammatory diseases. Their lead product, vilobelimab, targets conditions like hidradenitis suppurativa and vasculitis.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.